Taken together, these data support the hypothesis that RGS5 is associated with fibrosis and HSC activation in both tumor and non-tumor associated fibrosis, and that the observed up-regulation of RGS5 expression in fibrotic liver tumors [41], [42] may be due to tumor associated activated HSCs. Here, RGS5 is linked to neoplasm.